fbpx

PGT-Aneuploidy Screening

Ensuring a healthy and successful pregnancy

What is PGT-A

Viafet is a leading provider of Preimplantation Genetic Testing for Aneuploidy (PGT-A). This valuable tool allows us to detect any abnormalities in the 24 chromosomes of embryos generated through IVF. 

Indicators of PGT-A

  • Family balancing

  • Advanced reproductive age to avoid chromosomal abnormalities (>35 years)

  • Repeated IVF failure

  • History of recurrent pregnancy loss

  • History of chromosomal abnormality

  • Male factor infertility

Benefits of PGT-A

By using PGTA, you can select and transfer embryos that are free from aneuploidy, thereby increasing the chances of a successful pregnancy and a healthy child. PGT-A allows for:

  • Gender Determination 
  • Enhanced Implantation and Pregnancy Chances
  • Lower Risk of Miscarriage
  • Efficiency in Achieving Pregnancy
  • Increased Likelihood of a Healthy Child

PGT-A at Viafet

At Viafet, our Genomics Laboratory utilizes a unique and cost-effective in-house developed PGT-A approach using Next Generation Sequencing (NGS)  to allow us to screen embryos and accurately select chromosomally normal ones for transfer during an IVF procedure.

Viafet: 

Has successfully screened over 500.000 embryos

Uses the most up-to-date methodology and technology

Has accurate and precise detection (zero error rate)

A fast turn around time (24-36 hours)

Accepts biopsies on Day 3, 4, or 5 for Fresh or Frozen Embryo Transfer day 3,4 or 5

Other Reproductive Genetics Tests

An illustration of a cataract, a clouding of the eye's lens. Important for REPRODUCTIVE GENETICS.

Non-Invasive PGT-A

Pre-Implantation Genetic Testing- Monogenic Disorder (PGT-M)

Preimplantation Genetic Testing For Structural Rearrangement (PGT-SR)

SEND US A MESSAGE